Management of Polyomavirus-associated Nephropathy in Renal Transplant Recipients

Overview

Journal Nat Rev Nephrol

Specialty Nephrology

Date 2012 Apr 18

PMID 22508181

Citations 50

Authors

Dirk R J Kuypers

Affiliations

Soon will be listed here.

Abstract

Polyomavirus-associated nephropathy (PVAN) remains an important infectious complication after renal transplantation, affecting 1-10% of recipients and causing graft loss in approximately 50% of cases. With the lack of effective antiviral therapy, intensive monitoring for BK virus (BKV) using nucleic acid testing or urine cytology--in combination with a reduction of immunosuppressive therapy--is advocated to detect and prevent BKV reactivation and PVAN, respectively. In this Review, new insights into BKV biology and the development of PVAN are discussed. Clinical diagnostic approaches for the detection, surveillance and therapeutic monitoring of BKV are described. In addition, various strategies for reduction of immunosuppressive therapy are reviewed and an evaluation provided of the mechanisms of action and clinical effects of currently used adjuvant medication such as cidofovir, leflunomide, intravenous immunoglobulins and fluoroquinolone antibiotics. Finally, novel compounds and their in vitro actions against BKV are discussed together with future prospects for specific antiviral drug development.

Citing Articles

Target-specific peptides for BK virus agnoprotein identified through phage display screening: advancing antiviral therapeutics.

Xing X, Han J, Wang K, Tian F, Jiang C, Liang W Sci Rep. 2025; 15(1):2718.

PMID: 39837922 PMC: 11750963. DOI: 10.1038/s41598-025-86439-4.

Novel polyomavirus in the endangered garden dormouse Eliomys quercinus.

Vasiliunaite E, Repsyte M, Kramer E, Lang J, Jelinek C, Ulrich R Virol J. 2024; 21(1):309.

PMID: 39605065 PMC: 11603729. DOI: 10.1186/s12985-024-02581-x.

JC Polyomavirus Nephropathy: A Rare Complication Late after Kidney Transplantation.

Gerber J, De Marchi S, Gaspert A, Fehr T, Cippa P Case Rep Nephrol Dial. 2024; 14(1):148-157.

PMID: 39474252 PMC: 11521426. DOI: 10.1159/000540294.

BK Polyomavirus in Pediatric Renal Transplantation-What We Know and What We Do Not.

Chiodini B, Guillaume-Gentil P, Vanhomwegen C, Hennaut E, Lolin K, Tram N Biomedicines. 2024; 12(5).

PMID: 38791055 PMC: 11118040. DOI: 10.3390/biomedicines12051093.

Pretransplant BKV-IgG serostatus and BKV-specific ELISPOT assays to predict BKV infection after kidney transplantation.

Bae H, Jung S, Chung B, Yang C, Oh E Front Immunol. 2023; 14:1243912.

PMID: 37809095 PMC: 10551174. DOI: 10.3389/fimmu.2023.1243912.

References

Koukoulaki M, Grispou E, Pistolas D, Balaska K, Apostolou T, Anagnostopoulou M . Prospective monitoring of BK virus replication in renal transplant recipients. Transpl Infect Dis. 2008; 11(1):1-10. DOI: 10.1111/j.1399-3062.2008.00342.x. View

Manitpisitkul W, Drachenberg C, Ramos E, Munivenkatappa R, Philosophe B, Klassen D . Maintenance immunosuppressive agents as risk factors for BK virus nephropathy: a case-control study. Transplantation. 2009; 88(1):83-8. DOI: 10.1097/TP.0b013e3181aa8d93. View

Koukoulaki M, ODonovan M, Pursglove S, Alexopoulou D, Hadjiconstantinou V, Drakopoulos S . Prospective study of urine cytology screening for BK polyoma virus replication in renal transplant recipients. Cytopathology. 2008; 19(6):385-8. DOI: 10.1111/j.1365-2303.2008.00576.x. View

Kuypers D, Bammens B, Claes K, Evenepoel P, Lerut E, Vanrenterghem Y . A single-centre study of adjuvant cidofovir therapy for BK virus interstitial nephritis (BKVIN) in renal allograft recipients. J Antimicrob Chemother. 2008; 63(2):417-9. DOI: 10.1093/jac/dkn495. View

Wadei H, Rule A, Lewin M, Mahale A, Khamash H, Schwab T . Kidney transplant function and histological clearance of virus following diagnosis of polyomavirus-associated nephropathy (PVAN). Am J Transplant. 2006; 6(5 Pt 1):1025-32. DOI: 10.1111/j.1600-6143.2006.01296.x. View

Liacini A, Seamone M, Muruve D, Tibbles L . Anti-BK virus mechanisms of sirolimus and leflunomide alone and in combination: toward a new therapy for BK virus infection. Transplantation. 2010; 90(12):1450-7. DOI: 10.1097/TP.0b013e3182007be2. View

Laskin B, Goebel J . Cost-efficient screening for BK virus in pediatric kidney transplantation: a single-center experience and review of the literature. Pediatr Transplant. 2010; 14(5):589-95. DOI: 10.1111/j.1399-3046.2010.01318.x. View

Perets T, Silberstein I, Rubinov J, Sarid R, Mendelson E, Shulman L . High frequency and diversity of rearrangements in polyomavirus bk noncoding regulatory regions cloned from urine and plasma of Israeli renal transplant patients and evidence for a new genetic subtype. J Clin Microbiol. 2009; 47(5):1402-11. PMC: 2681874. DOI: 10.1128/JCM.02065-08. View

Bennett W, Meyer L, Ridenour J, Batiuk T . Surveillance and modification of immunosuppression minimizes BK virus nephropathy. Am J Nephrol. 2010; 32(1):10-2. DOI: 10.1159/000313888. View

10.

Sis B, Mengel M, Haas M, Colvin R, Halloran P, Racusen L . Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant. 2010; 10(3):464-71. DOI: 10.1111/j.1600-6143.2009.02987.x. View

11.

Singh H, Andreoni K, Madden V, True K, Detwiler R, Weck K . Presence of urinary Haufen accurately predicts polyomavirus nephropathy. J Am Soc Nephrol. 2009; 20(2):416-27. PMC: 2637054. DOI: 10.1681/ASN.2008010117. View

12.

Zhou W, Sharma M, Martinez J, Srivastava T, Diamond D, Knowles W . Functional characterization of BK virus-specific CD4+ T cells with cytotoxic potential in seropositive adults. Viral Immunol. 2007; 20(3):379-88. DOI: 10.1089/vim.2007.0030. View

13.

Bohl D, Storch G, Ryschkewitsch C, Gaudreault-Keener M, Schnitzler M, Major E . Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. Am J Transplant. 2005; 5(9):2213-21. DOI: 10.1111/j.1600-6143.2005.01000.x. View

14.

Waldman W, Knight D, Blinder L, Shen J, Lurain N, Miller D . Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide. Intervirology. 2000; 42(5-6):412-8. DOI: 10.1159/000053979. View

15.

Celik B, Shapiro R, Vats A, Randhawa P . Polyomavirus allograft nephropathy: sequential assessment of histologic viral load, tubulitis, and graft function following changes in immunosuppression. Am J Transplant. 2003; 3(11):1378-82. DOI: 10.1046/j.1600-6135.2003.00238.x. View

16.

Viscount H, Eid A, Espy M, Griffin M, Thomsen K, Harmsen W . Polyomavirus polymerase chain reaction as a surrogate marker of polyomavirus-associated nephropathy. Transplantation. 2007; 84(3):340-5. DOI: 10.1097/01.tp.0000275205.41078.51. View

17.

Randhawa P, Bohl D, Brennan D, Ruppert K, Ramaswami B, Storch G . longitudinal analysis of levels of immunoglobulins against BK virus capsid proteins in kidney transplant recipients. Clin Vaccine Immunol. 2008; 15(10):1564-71. PMC: 2565927. DOI: 10.1128/CVI.00206-08. View

18.

Bohl D, Brennan D, Ryschkewitsch C, Gaudreault-Keener M, Major E, Storch G . BK virus antibody titers and intensity of infections after renal transplantation. J Clin Virol. 2008; 43(2):184-9. PMC: 2701220. DOI: 10.1016/j.jcv.2008.06.009. View

19.

Hirsch H, Brennan D, Drachenberg C, Ginevri F, Gordon J, Limaye A . Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation. 2005; 79(10):1277-86. DOI: 10.1097/01.tp.0000156165.83160.09. View

20.

Hariharan S, Cohen E, Vasudev B, Orentas R, Viscidi R, Kakela J . BK virus-specific antibodies and BKV DNA in renal transplant recipients with BKV nephritis. Am J Transplant. 2005; 5(11):2719-24. DOI: 10.1111/j.1600-6143.2005.01080.x. View